发明授权
US08604055B2 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
有权
取代的苄基氨基喹啉作为胆固醇酯转移蛋白抑制剂
- 专利标题： Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
- 专利标题（中）： 取代的苄基氨基喹啉作为胆固醇酯转移蛋白抑制剂
-
申请号： US11478547申请日： 2006-06-28
-
公开(公告)号： US08604055B2公开(公告)日： 2013-12-10
- 发明人: Anima Baruah , Dibyendu De , Ish Kumar Khanna , Sivaram Pillarisetti , Santanu Maitra , Christopher W. Alexander , Jennepalli Sreenu , Indu Dagar , Shanavas Alikunju
- 申请人： Anima Baruah , Dibyendu De , Ish Kumar Khanna , Sivaram Pillarisetti , Santanu Maitra , Christopher W. Alexander , Jennepalli Sreenu , Indu Dagar , Shanavas Alikunju
- 申请人地址： IN Hyderabad
- 专利权人： Dr. Reddy's Laboratories Ltd.
- 当前专利权人： Dr. Reddy's Laboratories Ltd.
- 当前专利权人地址： IN Hyderabad
- 代理机构： Pergament Gilman & Cepeda LLP
- 代理商 Milagros A. Cepeda; Edward D. Pergament
- 主分类号： A61K31/4709
- IPC分类号： A61K31/4709 ; A61K31/496 ; A61K31/501 ; A61K31/53 ; A61K31/5377 ; C07D215/12 ; C07D413/14 ; C07D251/40 ; C07D239/42 ; A61P3/10 ; A61P9/10 ; A61P9/00 ; A61P9/12
摘要：
The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.